Xarelto Expert Witnesses in Virginia

This board certified expert has been practicing for over a decade. He earned a combined M.D.-Ph.D. from Virginia Commonwealth University prior to completing a residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at Seattle Children's Hospital. He holds membership in a multitude of prestigious medical organizations such as the American Society of Clinical Oncology and the American Society of Pediatric Hematology/Oncology, while he serves as a manuscript reviewer for over 10 medical journals, including "Cancer", "Frontiers in Pediatric Oncology", and "Annals of Oncology". Currently, this expert is an Associate Professor in the Division of Pediatric Hematology/Oncology at a major medical university, where he also serves as the Director of the Pediatric Sarcoma Program, the Adolescent and Young Adult Oncology Program, and the Pediatric Hematology/Oncology Fellowship Program.

This qualified expert has nearly a decade of board-certified experience in his field. He earned his undergraduate degree in premedical education from the Adamjee Government Science College and his MD from the Dow Medical College in Pakistan. He then worked as an administrator, medical officer, and house staff general surgeon in the Civil Hospital of Karachi. He then completed a residency in internal medicine at the University of Texas Medical Branch, Galveston before going on to complete a prestigious fellowship in hematology and oncology from Albert Einstein College/Montefiore Medical Center. This expert is triple board certified in internal medicine, hematology, and medical oncology. He is very active in his field as a member of multiple professional societies including the Society for Immunotherapy of Cancer, the European Society for Medical Oncology, the American Association of Cancer Research, the American Society of Hematology, and the American Society of Clinical Oncology. In addition, this expert has published over 40 peer-reviewed articles. Formerly, this expert served as a physician in hematology and oncology at the Greater Washington Oncology Associates and was the director of clinical oncology at Medimmune/AstraZeneca. He also was a clinical instructor for internal medicine residents at Prince George Hospital. Currently, this expert is a clinical program lead for a biotechnology company and he is an independent practicing physician in hematology and oncology.